1. X
  2. NICE
Log inSign up
NICE
17.3K posts
Image
user avatar
NICE
@NICEComms
Official feed of NICE - National Institute for Health and Care Excellence. We produce evidence-based health and social care guidance. Tweets by the comms team.
London and Manchester, UK
nice.org.uk
Joined October 2009
1,095
Following
236.9K
Followers
RepliesRepliesMediaMedia
Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

  • user avatar
    NICE
    @NICEComms
    Jul 23
    How can #healthtech transform heart failure care? For Gavin, TriageHF remotely detected warning signs before symptoms appeared, helping his clinical team act quickly and supporting earlier intervention. Read his story: nice.org.uk/news/blogs/the… @pumpinghearts @MFTnhs
    Image
    00:00
    5K
  • user avatar
    NICE
    @NICEComms
    Jul 21
    This time on #NICEtalks, we discuss teplizumab for NHS use, the first treatment to delay the onset of symptomatic type 1 diabetes by an average of nearly three years:
    nice.org.uk
    Changing the course: the NHS's first treatment to delay type 1 diabetes
    2.7K
  • user avatar
    NICE
    @NICEComms
    Jul 20
    "No one can understand the process as well as a patient." Debra survived a heart attack at 38 and joined a NICE committee as a lay member to help shape our digital cardiac rehabilitation guidance. Patient perspective is at the heart of everything we do: indepth.nice.org.uk/from-patient-t…
    Image
    00:00
    2.4K
  • user avatar
    NICE
    @NICEComms
    Jul 15
    New NICE guidance: Deuruxolitinib is now recommended for severe alopecia areata. The twice-daily pill could help over 13,000 people in England living with this autoimmune condition. Read the final guidance: nice.org.uk/guidance/indev…
    Image
    00:00
    2.6K
  • user avatar
    NICE
    @NICEComms
    Jul 14
    We've recommended pembrolizumab with chemoradiotherapy for around 280 adults with untreated advanced cervical cancer. Helping people to live longer, it slows cancer progression compared with chemoradiotherapy alone. Read the final guidance: nice.org.uk/guidance/ta117…
    Image
    00:00
    1.7K
Advertisement
Advertisement